The Cornerstone of Target Discovery and Drug Screening: Application and Cost Control of High-Purity Recombinant Proteins in In Vitro Models

Author: Senior Product Manager of UA Views：10

In the long chain of new drug development, from target discovery and lead compound screening to preclinical toxicology assessment, in vitro cell models have always been a key link in predicting drug efficacy and safety. Recombinant cytokines and target proteins, as the "bricks" for building these models, have their purity, activity, and batch-to-batch stability directly related to the reliability of experimental data.

Recent Advances

Recent Advances

The Cornerstone of Target Discovery and Drug Screening: Application and Cost Control of High-Purity Recombinant Proteins in In Vitro Models

Brief Introduction: In the lengthy chain of new drug development, from target discovery and lead compound screening to preclinical toxicology assessment, in vitro cell models have always been a key link in predicting drug efficacy and safety. Recombinant cytokines and target proteins, as the "bricks" for constructing these models, have their purity, activity, and batch-to-batch stability directly related to the reliability of experimental data. Facing increasingly growing R&D costs, how to achieve cost reduction and efficiency improvement while ensuring data quality is a topic that every research manager must consider.

I. The Core Role of Target Proteins and Cytokines in Drug Discovery

In vitro models at the drug discovery stage need to highly restore the physiological or pathological state in the human body. For example, in the development of tumor immunotherapy drugs, the use of cytokines such as IL-2 and IL-15 to induce and expand NK cells in vitro is the basis for evaluating antibody-dependent cell-mediated cytotoxicity. In the construction of autoimmune disease models, the synergistic effect of TGF-β, IL-6, and IL-23 is widely used to induce Th17 cell differentiation in order to screen inhibitors targeting the IL-17 pathway.

In addition, vaccine development or neutralizing antibody screening against viral antigens also depends on high-purity viral antigen proteins and recombinant cytokines. These biological macromolecules in in vitro experiments are not only nutrient sources for cells, but also the "keys" to activating specific signaling pathways. If the endotoxin of recombinant proteins exceeds the standard or the spatial conformation is incorrectly folded, it will directly lead to cell activation failure or false positive/false negative results.

II. Factor Combination Strategies in Immune Cell Culture Systems

Establishing a robust in vitro culture system requires scientific compatibility of cytokines. In macrophage polarization experiments, M-CSF is responsible for basal proliferation, while IL-4 and IL-13 are used to induce the M2 phenotype to study immunosuppressive mechanisms in the tumor microenvironment. In the development of DC vaccines, GM-CSF and IL-4 jointly induce immature DCs, which are subsequently promoted to mature by factors such as TNF-α and IL-1β. This process is crucial for evaluating T cell antigen presentation ability.

For in vitro expansion of T cells, IL-2 is an indispensable basal factor, while the addition of IL-7 and IL-21 helps maintain T cell stemness and memory phenotype, which has important guiding significance for the development of in vitro manufacturing processes for cell therapy products such as CAR-T.

III. Technological Breakthroughs of Domestic Brands in the Field of Recombinant Protein Engineering

For a long time, the market for high-purity recombinant cytokines has been mostly occupied by imported brands, resulting in persistently high research costs. In recent years, domestic brands represented by Ua-Bio have made significant progress in gene synthesis optimization, expression system selection (such as mammalian cell expression systems to ensure correct post-translational modifications), and multi-step chromatography purification processes.

A strict quality control system ensures that products have extremely low endotoxin levels and excellent batch-to-batch consistency, which provides a stable material foundation for long-term, large-scale drug screening experiments. The rise of domestic recombinant proteins has not only broken technical barriers, but also provided a cost-effective alternative for the domestic scientific research community, so that cutting-edge scientific research is no longer limited by high reagent costs.

IV. Ua-Bio Special Promotion Campaign and Purchasing Guide

In order to effectively reduce the burden on scientific research, Ua-Bio launched a special benefit campaign titled "Halve Research Costs, Not Quality" from October 26 to October 31, 2026 (promotion code: UA2610). This campaign covers more than 300 types of recombinant cytokines, with direct price reductions for all specifications and a limited-time 50% discount.

Researchers can view the detailed product list by scanning the official QR code. The campaign rules clearly state that the discount is only for end customers, and distributors do not participate; at the same time, in case of product shortage or discontinuation, the supplier has the right to cancel the order. Adhering to the service philosophy of "Buy proteins (domestic), find Ua-Bio; drug discovery, all in one stop," Ua-Bio provides one-stop procurement and technical support through its official website (www.ua-bio.com). It is recommended that each research group reasonably utilize this promotion window in combination with recent drug screening plans, in order to ensure the smooth construction of high-quality in vitro models while controlling R&D costs.

This article is reviewed and published by the technical expert team of UA

Disclaimer: This article partially utilizes artificial intelligence assistance in its creation. If any content involves copyright or intellectual property issues, please let us know and we promise to verify and remove it as soon as possible.

Purchase recombinant protein, choose

UA protein focuses on providing various protein reagents, raw materials, and services required for drug research and development, cell therapy, gene therapy, and basic scientific research, including drug target proteins, immune checkpoint proteins, cytokines, tool enzymes, customized protein expression, and full-length transmembrane protein development. Nanjing Univ is committed to providing customers with high-quality products and professional services, and building a High-tech Biological Enterprise with International Competitiveness.

Buy antibodiesFind UA www.ua-bio.com | 15 years of protein development experience

Nanjing UNIV Biotechnology Co., Ltd. Email：order@ua-bio.com Phone：+86-25-56221161

more products

The Last The Next